Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bare-metal Stents(BMS) Versus Drug-eluting Stents(DES) in Patients Who Underwent Periprocedural Blood Transfusion : A Nationwide Longitudinal Cohort Study

NCT03788148 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03788148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03788148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bare-metal Stents(BMS) Versus Drug-eluting Stents(DES) in Patients Who Underwent Periprocedural Blood Transfusion : A Nationwide Longitudinal Cohort Study
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
January 3, 2018
Completion date
November 30, 2018
Enrollment
28,322 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythrocyte transfusion, percutaneous coronary intervention, revascularization